ABL Diagnostics Logo

ABL Diagnostics

ISIN

FR001400AHX6

Ticker

ABLD

Sector

Health Care

Sub-Industry

Health Care Technology

Country

France

Year Founded

2000

About ABL Diagnostics

Company Description

Advanced Biological Laboratories (ABL), S.A., is a diagnostic and medical software company founded in 2000 as a spin-off from CRP-Santé (https://www.lih.lu/) Luxembourg.

ABL’s products offer to infectious disease clinicians, virology and microbiology laboratories.

Assays and standalone software systems for accredited laboratories (i.e. ISO 15189), mainly for microbiology applications (related to HIV, SARS-CoV-2, Tuberculosis, HCV, HBV, HPV, CMV, HPV, Flu, 16s RNA…) for clinical genotyping through sequencing (DeepChek®), DNA and RNA detection and quantification (UltraGene®), including powerful downstream analysis software applications fully integrated with knowledge databases and analysis systems for capillary and high-throughput Next Generation Sequencing data.

Clinical software applications for infectious diseases units

IT dashboards and clinical database aggregation applications for research and clinical management

Served Area

Worldwide

Headquarters

Bât E1 42 Rue Olivier Métra
75020, Paris
France

Capital Markets Information

ISIN

FR001400AHX6

LEI

9695002UO0UHM0VKRH38

Listed Stock Exchange

Euronext Paris

Contact Investor Relations Department

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.